EXT2 and glioblastoma: Importantly, Ferrostatin-1 pretreatment counteracted the radiosensitizing effect of EXT2 silencing in both tested GBM cell models relative to controls, while an effect on basal cytotoxicity was lacking (Fig. 6C, Supplementary Fig. S8).